Author:
Fahrig Rudolf,Quietzsch Detlef,Heinrich Jörg-Christian,Heinemann Volker,Boeck Stefan,Schmid Roland M.,Praha Christian,Liebert Andreas,Sonntag Denise,Krupitza Georg,Hänel Mathias
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Reference37 articles.
1. Inhibition of induced chemoresistance by cotreatment with (E)-5-(2-bromovinyl)-2′-deoxyuridine (RP101);Fahrig;Cancer Res,2003
2. A phase II trial comparing gemcitabine plus cisplatin vs. Gemcitabine alone in advanced pancreatic cancer;Heinemann;Proc Am Soc Clin Oncol,2003
3. Morphometric analysis of cytolysis in cultured cell monolayers: a simple and versatile method for the evaluation of the lytic activity and the fate of LAK cells;De Meyer;J Immunol Methods,2003
4. Molecular cloning. 3rd ed;Sambrook,2001
5. Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides;Lau;Br J Cancer,2004
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献